Central University of Tamil Nadu has invited online application for admission to Part Time 4-years Ph.D through Entrance test.
Last date for submission of online application form
25th October 2020
Date of Entrance Exam
To be announced
Entrance Exam Centers
Chennai & Thiruvarur
Ph.D Program offered
Epidemiology & Public Health
A consistently good academic record possessing a Master’s Degree (two years duration) or M.Phil. degree with a minimum of 55% marks [50% for OBC (Non-creamy layer) / SC/ST/PWD candidates] preceded by a Bachelor’s Degree or an equivalent Degree of three years duration from a recognized University/Institute.
Passed M.A./M.Sc. or M.Phil./ MBA or Post Graduation in Financial Economics / Econometrics / Statistics or Equivalent or ACA/ACS/CMA or M.Phil. in Commerce / Management / Financial Economics / Statistics of Equivalent obtained from any recognized Indian University or its equivalent, with a minimum of 55% marks for General category and 50% marks for OBC/SC/ST/PWD categories at P.G level.
Those who have appeared for final year P.G. Degree Exams and waiting for the result also can apply.
For For General and OBC candidates
For SC/ST candidates
For PWD candidates
Mode of Payment
Online Through Debit card/Credit card/Net Banking/SBI collect
Candidates desirous of applying for more than one programmes have to apply separately with different Email I.D and make separate payment.
The candidates are required to submit the application through proper channel endorsed by the appropriate authority in his/her organization to pursue studies on a part-time basis
The applicants are advised to take a print out of the submitted application for future reference.
Admission will be done through a two stage process.
An entrance test with qualifying marks as 50% (45% and for OBC-NCL, SC, ST & PWD candidates). The syllabus of the entrance test shall consist of 50% or research methodology and 50% shall be subject specific.
For selection of candidates, a weightage of 70% to the entrance test and 30% to the performance in the Interview/Viva-voce.